schizophrenia – Page 115 – News and resources

Sep 26 2024

Most People With Schizophrenia Aren’t Getting Treated

by Clinical Editor

No Comments

Bareis’ team found that, besides being diagnosed with schizophrenia, more than half (52%) of these patients also had depression, while 17% had been diagnosed with post-traumatic stress disorder (PTSD) …

Sep 26 2024

Uncategorized

Synapse-restoring pill set for human trials as novel schizophrenia treatment

by Clinical Editor

No Comments

Spinogenix, the company behind the once-a-day pill that restored lost nerve cell connections in people with amyotrophic lateral sclerosis (ALS), has now set its sights on using the pill to...

Sep 25 2024

Uncategorized

What to know about flat affect in schizophrenia

by Clinical Editor

No Comments

Flat affect is a possible symptom of schizophrenia. It is a term for a lack of emotional response. Learn more here.

Sep 25 2024

Uncategorized

The ‘game-changing’ treatment for schizophrenia

by Clinical Editor

No Comments

US poised to approve KarXT as new antipsychotic treatment for disorder, which could offer reduced side-effects …

Sep 24 2024

Uncategorized

Court orders man with ‘schizophrenia’ to enter defence over his father’s murder

by Clinical Editor

No Comments

PUTRAJAYA: The Court of Appeal on Tuesday (Sept 24) ordered a man to defend himself on the charge of killing his biological father by hitting him with a stick and...

Sep 24 2024

Uncategorized

New research identifies critical gaps in mental health care for adults with schizophrenia spectrum disorders

by Clinical Editor

No Comments

New research finds that adults with schizophrenia spectrum disorders have high rates of comorbid mental and substance use disorders and significant social and economic disadvantages, and only 26% received minimally...

Sep 23 2024

Uncategorized

Owning a Cat Could Double Your Schizophrenia Risk, Research Suggests

by Clinical Editor

No Comments

Having a cat as a pet could potentially double a person’s risk of schizophrenia-related disorders, according to a recent study. Australian researchers conducted an analysis of 17 studies published …

Sep 23 2024

Uncategorized

Schizophrenia Space Anticipates First-in-Class FDA Approval for BMS’ KarXT

by Clinical Editor

No Comments

With an FDA action date of Sept. 26, Bristol Myers Squibb’s KarXT could soon be the first new type of schizophrenia drug in three decades—and the company also sees potential...

Sep 22 2024

Uncategorized